Form4insider filings, from the source

SEC Form 4 · accession 0001225208-16-035327

PORTOLA PHARMACEUTICALS INC · PTLA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 17, 2016
Accepted (ET)
Jun 21, 2016 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 17, 2016A3,000$0.00A3,000D
Common StockF3holding———36,602IBy Ltd Partnership (NEST)
Common StockF4holding———958,491IBy Ltd Partnership (SHV)
Common StockF5holding———59,053IBy Trust (Trustees)

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2,F6$24.19Jun 17, 2016A6,000A—Jun 1, 2026Common Stock6,0006,000D

Explanation of responses